Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1166588 NEW YORK, NY
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$30,892,190
-$31,819,839 QoQ
Shares Held
378,720
-58.9% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#55
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. PTCT ranks #38 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in PTCT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,892,190 378,720
2026-03-31 $62,712,029 920,476
2025-12-31 $62,945,165 828,662
2025-09-30 $1,236,421 20,147
2025-06-30 $630,231 12,904
2025-03-31 $284,102 5,575
2024-12-31 $464,580 10,292
2024-09-30 $2,706,296 72,946
2024-06-30 $3,902,038 127,601
2024-03-31 $5,808,400 199,670
2023-12-31 $10,240,744 371,580
2023-09-30 $2,292,274 102,288
2023-06-30 $2,307,412 56,735
2023-03-31 $3,819,833 78,857
2022-12-31 $2,555,901 66,961
2022-09-30 $3,510,084 69,922
2022-06-30 $1,344,734 33,568
2022-03-31 $1,052,179 28,201
2021-12-31 $580,044 14,563
2021-09-30 $465,757 12,517
2021-06-30 $109,521 2,591
2021-03-31 $374,207 7,903
2020-12-31 $565,259 9,262
2020-09-30 $683,157 14,613
2020-06-30 $339,349 6,688
2020-03-31 $3,382,062 75,814